Beckman Coulter is the combination of two highly successful companies with distinguished histories. Beckman Instruments, Inc. (founded in the USA in 1934) and Coulter Corporation (founded in the late 1940s) united in 1997 to form a single entity that accounts for tens of thousands of analytical systems operating in laboratories around the world. The Corporation is a world leader in providing systems that simplify and automate laboratory processes used in all phases of the battle against disease. Beckman Coulter designs, manufacture, market and service a broad range of laboratory systems consisting of instruments, chemistries, software, and supplies that meet a variety of laboratory needs. Beckman Coulter products are used in a range of applications, from instruments used for pioneering medical research and drug discovery to diagnostic tools found in hospitals and physicians’ offices.

The Company’s diagnostics product lines cover virtually all blood tests routinely performed in hospital laboratories. For medical and pharmaceutical research, they provide a wide range of systems used in genomic, cellular and protein testing. The Company has approximately 125 000 systems operating in laboratories around the world, with 68% of annual revenues coming from after-market customer purchases of operating supplies, chemistry kits and service. Beckman Coulter markets their products in approximately 130 countries.

The Australian subsidiary was established in 1981 and is responsible for business in Australia and New Zealand and territories in the South Pacific. Beckman Coulter is headquartered in Sydney and Auckland with strategic service depots in the other major Australian cities.